nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamsulosin—CYP3A4—bone cancer	0.869	1	CbGaD
Tamsulosin—Silodosin—CYP3A4—bone cancer	0.00462	0.616	CrCbGaD
Tamsulosin—Bumetanide—PTGS2—bone cancer	0.00174	0.232	CrCbGaD
Tamsulosin—Carvedilol—CYP3A4—bone cancer	0.00114	0.151	CrCbGaD
Tamsulosin—Lung disorder—Doxorubicin—bone cancer	0.000986	0.00962	CcSEcCtD
Tamsulosin—Amblyopia—Epirubicin—bone cancer	0.000976	0.00953	CcSEcCtD
Tamsulosin—Orthostatic hypotension—Cisplatin—bone cancer	0.000973	0.0095	CcSEcCtD
Tamsulosin—Breast disorder—Cisplatin—bone cancer	0.000963	0.0094	CcSEcCtD
Tamsulosin—Nasopharyngitis—Cisplatin—bone cancer	0.000953	0.0093	CcSEcCtD
Tamsulosin—Amblyopia—Doxorubicin—bone cancer	0.000903	0.00882	CcSEcCtD
Tamsulosin—Cough increased—Epirubicin—bone cancer	0.000824	0.00804	CcSEcCtD
Tamsulosin—Skin exfoliation—Methotrexate—bone cancer	0.000769	0.00751	CcSEcCtD
Tamsulosin—Neck pain—Epirubicin—bone cancer	0.000763	0.00745	CcSEcCtD
Tamsulosin—Cough increased—Doxorubicin—bone cancer	0.000762	0.00744	CcSEcCtD
Tamsulosin—Influenza like illness—Epirubicin—bone cancer	0.000732	0.00715	CcSEcCtD
Tamsulosin—Connective tissue disorder—Cisplatin—bone cancer	0.000724	0.00707	CcSEcCtD
Tamsulosin—Skin exfoliation—Epirubicin—bone cancer	0.00072	0.00703	CcSEcCtD
Tamsulosin—Visual impairment—Cisplatin—bone cancer	0.00071	0.00694	CcSEcCtD
Tamsulosin—Neck pain—Doxorubicin—bone cancer	0.000706	0.00689	CcSEcCtD
Tamsulosin—Cardiac disorder—Cisplatin—bone cancer	0.000684	0.00668	CcSEcCtD
Tamsulosin—Influenza like illness—Doxorubicin—bone cancer	0.000677	0.00661	CcSEcCtD
Tamsulosin—Skin exfoliation—Doxorubicin—bone cancer	0.000666	0.0065	CcSEcCtD
Tamsulosin—Mediastinal disorder—Cisplatin—bone cancer	0.000664	0.00649	CcSEcCtD
Tamsulosin—Hypertonia—Epirubicin—bone cancer	0.000661	0.00645	CcSEcCtD
Tamsulosin—Arrhythmia—Cisplatin—bone cancer	0.000659	0.00643	CcSEcCtD
Tamsulosin—Malnutrition—Cisplatin—bone cancer	0.000642	0.00627	CcSEcCtD
Tamsulosin—Dermatitis exfoliative—Methotrexate—bone cancer	0.00062	0.00605	CcSEcCtD
Tamsulosin—Hypertonia—Doxorubicin—bone cancer	0.000611	0.00597	CcSEcCtD
Tamsulosin—Vision blurred—Cisplatin—bone cancer	0.000605	0.0059	CcSEcCtD
Tamsulosin—Ill-defined disorder—Cisplatin—bone cancer	0.000595	0.00581	CcSEcCtD
Tamsulosin—Dermatitis exfoliative—Epirubicin—bone cancer	0.00058	0.00566	CcSEcCtD
Tamsulosin—Malaise—Cisplatin—bone cancer	0.000579	0.00565	CcSEcCtD
Tamsulosin—Myalgia—Cisplatin—bone cancer	0.000546	0.00533	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000543	0.0053	CcSEcCtD
Tamsulosin—Discomfort—Cisplatin—bone cancer	0.00054	0.00527	CcSEcCtD
Tamsulosin—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000537	0.00524	CcSEcCtD
Tamsulosin—Breast disorder—Methotrexate—bone cancer	0.000528	0.00516	CcSEcCtD
Tamsulosin—Infection—Cisplatin—bone cancer	0.00052	0.00508	CcSEcCtD
Tamsulosin—Nervous system disorder—Cisplatin—bone cancer	0.000514	0.00501	CcSEcCtD
Tamsulosin—Tachycardia—Cisplatin—bone cancer	0.000511	0.00499	CcSEcCtD
Tamsulosin—Skin disorder—Cisplatin—bone cancer	0.000509	0.00497	CcSEcCtD
Tamsulosin—Hyperhidrosis—Cisplatin—bone cancer	0.000506	0.00494	CcSEcCtD
Tamsulosin—Orthostatic hypotension—Epirubicin—bone cancer	0.0005	0.00488	CcSEcCtD
Tamsulosin—Breast disorder—Epirubicin—bone cancer	0.000495	0.00483	CcSEcCtD
Tamsulosin—Hypotension—Cisplatin—bone cancer	0.000489	0.00478	CcSEcCtD
Tamsulosin—Nasopharyngitis—Epirubicin—bone cancer	0.000489	0.00478	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000477	0.00466	CcSEcCtD
Tamsulosin—Influenza—Epirubicin—bone cancer	0.000473	0.00462	CcSEcCtD
Tamsulosin—Dysuria—Methotrexate—bone cancer	0.000473	0.00461	CcSEcCtD
Tamsulosin—Paraesthesia—Cisplatin—bone cancer	0.00047	0.00459	CcSEcCtD
Tamsulosin—Dyspnoea—Cisplatin—bone cancer	0.000467	0.00456	CcSEcCtD
Tamsulosin—Erectile dysfunction—Methotrexate—bone cancer	0.000466	0.00454	CcSEcCtD
Tamsulosin—Orthostatic hypotension—Doxorubicin—bone cancer	0.000462	0.00452	CcSEcCtD
Tamsulosin—Breast disorder—Doxorubicin—bone cancer	0.000458	0.00447	CcSEcCtD
Tamsulosin—Nasopharyngitis—Doxorubicin—bone cancer	0.000453	0.00442	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Cisplatin—bone cancer	0.000452	0.00441	CcSEcCtD
Tamsulosin—Infestation NOS—Methotrexate—bone cancer	0.000451	0.0044	CcSEcCtD
Tamsulosin—Infestation—Methotrexate—bone cancer	0.000451	0.0044	CcSEcCtD
Tamsulosin—Pain—Cisplatin—bone cancer	0.000448	0.00437	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000447	0.00436	CcSEcCtD
Tamsulosin—Dysuria—Epirubicin—bone cancer	0.000442	0.00432	CcSEcCtD
Tamsulosin—Influenza—Doxorubicin—bone cancer	0.000438	0.00427	CcSEcCtD
Tamsulosin—Sweating—Methotrexate—bone cancer	0.000432	0.00422	CcSEcCtD
Tamsulosin—Feeling abnormal—Cisplatin—bone cancer	0.000432	0.00421	CcSEcCtD
Tamsulosin—Epistaxis—Methotrexate—bone cancer	0.000425	0.00415	CcSEcCtD
Tamsulosin—Infestation NOS—Epirubicin—bone cancer	0.000422	0.00412	CcSEcCtD
Tamsulosin—Infestation—Epirubicin—bone cancer	0.000422	0.00412	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000418	0.00408	CcSEcCtD
Tamsulosin—Body temperature increased—Cisplatin—bone cancer	0.000414	0.00404	CcSEcCtD
Tamsulosin—Urinary tract infection—Epirubicin—bone cancer	0.00041	0.004	CcSEcCtD
Tamsulosin—Dysuria—Doxorubicin—bone cancer	0.000409	0.004	CcSEcCtD
Tamsulosin—Sweating—Epirubicin—bone cancer	0.000404	0.00395	CcSEcCtD
Tamsulosin—Pharyngitis—Methotrexate—bone cancer	0.000402	0.00392	CcSEcCtD
Tamsulosin—Epistaxis—Epirubicin—bone cancer	0.000398	0.00388	CcSEcCtD
Tamsulosin—Sinusitis—Epirubicin—bone cancer	0.000396	0.00386	CcSEcCtD
Tamsulosin—Infestation NOS—Doxorubicin—bone cancer	0.00039	0.00381	CcSEcCtD
Tamsulosin—Infestation—Doxorubicin—bone cancer	0.00039	0.00381	CcSEcCtD
Tamsulosin—Visual impairment—Methotrexate—bone cancer	0.00039	0.00381	CcSEcCtD
Tamsulosin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000387	0.00378	CcSEcCtD
Tamsulosin—Hypersensitivity—Cisplatin—bone cancer	0.000386	0.00377	CcSEcCtD
Tamsulosin—Erythema multiforme—Methotrexate—bone cancer	0.000383	0.00373	CcSEcCtD
Tamsulosin—Rhinitis—Epirubicin—bone cancer	0.00038	0.00371	CcSEcCtD
Tamsulosin—Urinary tract infection—Doxorubicin—bone cancer	0.000379	0.0037	CcSEcCtD
Tamsulosin—Asthenia—Cisplatin—bone cancer	0.000376	0.00367	CcSEcCtD
Tamsulosin—Pharyngitis—Epirubicin—bone cancer	0.000376	0.00367	CcSEcCtD
Tamsulosin—Cardiac disorder—Methotrexate—bone cancer	0.000375	0.00367	CcSEcCtD
Tamsulosin—Sweating—Doxorubicin—bone cancer	0.000374	0.00365	CcSEcCtD
Tamsulosin—Oedema peripheral—Epirubicin—bone cancer	0.000373	0.00364	CcSEcCtD
Tamsulosin—Connective tissue disorder—Epirubicin—bone cancer	0.000372	0.00363	CcSEcCtD
Tamsulosin—Epistaxis—Doxorubicin—bone cancer	0.000368	0.00359	CcSEcCtD
Tamsulosin—Angiopathy—Methotrexate—bone cancer	0.000367	0.00358	CcSEcCtD
Tamsulosin—Sinusitis—Doxorubicin—bone cancer	0.000366	0.00357	CcSEcCtD
Tamsulosin—Visual impairment—Epirubicin—bone cancer	0.000365	0.00356	CcSEcCtD
Tamsulosin—Mediastinal disorder—Methotrexate—bone cancer	0.000365	0.00356	CcSEcCtD
Tamsulosin—Chills—Methotrexate—bone cancer	0.000363	0.00354	CcSEcCtD
Tamsulosin—Diarrhoea—Cisplatin—bone cancer	0.000358	0.0035	CcSEcCtD
Tamsulosin—Erythema multiforme—Epirubicin—bone cancer	0.000358	0.00349	CcSEcCtD
Tamsulosin—Malnutrition—Methotrexate—bone cancer	0.000352	0.00344	CcSEcCtD
Tamsulosin—Cardiac disorder—Epirubicin—bone cancer	0.000351	0.00343	CcSEcCtD
Tamsulosin—Rhinitis—Doxorubicin—bone cancer	0.000351	0.00343	CcSEcCtD
Tamsulosin—Pharyngitis—Doxorubicin—bone cancer	0.000348	0.00339	CcSEcCtD
Tamsulosin—Oedema peripheral—Doxorubicin—bone cancer	0.000345	0.00337	CcSEcCtD
Tamsulosin—Connective tissue disorder—Doxorubicin—bone cancer	0.000344	0.00336	CcSEcCtD
Tamsulosin—Angiopathy—Epirubicin—bone cancer	0.000344	0.00335	CcSEcCtD
Tamsulosin—Mediastinal disorder—Epirubicin—bone cancer	0.000341	0.00333	CcSEcCtD
Tamsulosin—Back pain—Methotrexate—bone cancer	0.000341	0.00333	CcSEcCtD
Tamsulosin—Chills—Epirubicin—bone cancer	0.00034	0.00332	CcSEcCtD
Tamsulosin—Arrhythmia—Epirubicin—bone cancer	0.000338	0.0033	CcSEcCtD
Tamsulosin—Visual impairment—Doxorubicin—bone cancer	0.000338	0.0033	CcSEcCtD
Tamsulosin—Vomiting—Cisplatin—bone cancer	0.000333	0.00325	CcSEcCtD
Tamsulosin—Vision blurred—Methotrexate—bone cancer	0.000332	0.00324	CcSEcCtD
Tamsulosin—Erythema multiforme—Doxorubicin—bone cancer	0.000331	0.00323	CcSEcCtD
Tamsulosin—Rash—Cisplatin—bone cancer	0.00033	0.00322	CcSEcCtD
Tamsulosin—Dermatitis—Cisplatin—bone cancer	0.00033	0.00322	CcSEcCtD
Tamsulosin—Malnutrition—Epirubicin—bone cancer	0.00033	0.00322	CcSEcCtD
Tamsulosin—Ill-defined disorder—Methotrexate—bone cancer	0.000327	0.00319	CcSEcCtD
Tamsulosin—Cardiac disorder—Doxorubicin—bone cancer	0.000325	0.00317	CcSEcCtD
Tamsulosin—Back pain—Epirubicin—bone cancer	0.000319	0.00311	CcSEcCtD
Tamsulosin—Angiopathy—Doxorubicin—bone cancer	0.000318	0.0031	CcSEcCtD
Tamsulosin—Malaise—Methotrexate—bone cancer	0.000318	0.0031	CcSEcCtD
Tamsulosin—Vertigo—Methotrexate—bone cancer	0.000316	0.00309	CcSEcCtD
Tamsulosin—Mediastinal disorder—Doxorubicin—bone cancer	0.000316	0.00308	CcSEcCtD
Tamsulosin—Chills—Doxorubicin—bone cancer	0.000314	0.00307	CcSEcCtD
Tamsulosin—Arrhythmia—Doxorubicin—bone cancer	0.000313	0.00306	CcSEcCtD
Tamsulosin—Nausea—Cisplatin—bone cancer	0.000311	0.00304	CcSEcCtD
Tamsulosin—Vision blurred—Epirubicin—bone cancer	0.000311	0.00303	CcSEcCtD
Tamsulosin—Cough—Methotrexate—bone cancer	0.000307	0.003	CcSEcCtD
Tamsulosin—Ill-defined disorder—Epirubicin—bone cancer	0.000306	0.00299	CcSEcCtD
Tamsulosin—Malnutrition—Doxorubicin—bone cancer	0.000305	0.00298	CcSEcCtD
Tamsulosin—Arthralgia—Methotrexate—bone cancer	0.0003	0.00293	CcSEcCtD
Tamsulosin—Chest pain—Methotrexate—bone cancer	0.0003	0.00293	CcSEcCtD
Tamsulosin—Myalgia—Methotrexate—bone cancer	0.0003	0.00293	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000298	0.00291	CcSEcCtD
Tamsulosin—Malaise—Epirubicin—bone cancer	0.000297	0.0029	CcSEcCtD
Tamsulosin—Discomfort—Methotrexate—bone cancer	0.000296	0.00289	CcSEcCtD
Tamsulosin—Vertigo—Epirubicin—bone cancer	0.000296	0.00289	CcSEcCtD
Tamsulosin—Syncope—Epirubicin—bone cancer	0.000296	0.00289	CcSEcCtD
Tamsulosin—Back pain—Doxorubicin—bone cancer	0.000295	0.00288	CcSEcCtD
Tamsulosin—Palpitations—Epirubicin—bone cancer	0.000291	0.00284	CcSEcCtD
Tamsulosin—Loss of consciousness—Epirubicin—bone cancer	0.00029	0.00283	CcSEcCtD
Tamsulosin—Cough—Epirubicin—bone cancer	0.000288	0.00281	CcSEcCtD
Tamsulosin—Vision blurred—Doxorubicin—bone cancer	0.000287	0.00281	CcSEcCtD
Tamsulosin—Infection—Methotrexate—bone cancer	0.000286	0.00279	CcSEcCtD
Tamsulosin—Hypertension—Epirubicin—bone cancer	0.000285	0.00278	CcSEcCtD
Tamsulosin—Ill-defined disorder—Doxorubicin—bone cancer	0.000283	0.00276	CcSEcCtD
Tamsulosin—Nervous system disorder—Methotrexate—bone cancer	0.000282	0.00275	CcSEcCtD
Tamsulosin—Arthralgia—Epirubicin—bone cancer	0.000281	0.00274	CcSEcCtD
Tamsulosin—Chest pain—Epirubicin—bone cancer	0.000281	0.00274	CcSEcCtD
Tamsulosin—Myalgia—Epirubicin—bone cancer	0.000281	0.00274	CcSEcCtD
Tamsulosin—Skin disorder—Methotrexate—bone cancer	0.000279	0.00273	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000279	0.00272	CcSEcCtD
Tamsulosin—Hyperhidrosis—Methotrexate—bone cancer	0.000278	0.00271	CcSEcCtD
Tamsulosin—Discomfort—Epirubicin—bone cancer	0.000277	0.00271	CcSEcCtD
Tamsulosin—Malaise—Doxorubicin—bone cancer	0.000275	0.00268	CcSEcCtD
Tamsulosin—Vertigo—Doxorubicin—bone cancer	0.000274	0.00267	CcSEcCtD
Tamsulosin—Syncope—Doxorubicin—bone cancer	0.000273	0.00267	CcSEcCtD
Tamsulosin—Palpitations—Doxorubicin—bone cancer	0.000269	0.00263	CcSEcCtD
Tamsulosin—Hypotension—Methotrexate—bone cancer	0.000269	0.00262	CcSEcCtD
Tamsulosin—Loss of consciousness—Doxorubicin—bone cancer	0.000268	0.00262	CcSEcCtD
Tamsulosin—Infection—Epirubicin—bone cancer	0.000267	0.00261	CcSEcCtD
Tamsulosin—Cough—Doxorubicin—bone cancer	0.000266	0.0026	CcSEcCtD
Tamsulosin—Shock—Epirubicin—bone cancer	0.000265	0.00258	CcSEcCtD
Tamsulosin—Nervous system disorder—Epirubicin—bone cancer	0.000264	0.00258	CcSEcCtD
Tamsulosin—Hypertension—Doxorubicin—bone cancer	0.000263	0.00257	CcSEcCtD
Tamsulosin—Tachycardia—Epirubicin—bone cancer	0.000263	0.00256	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000262	0.00256	CcSEcCtD
Tamsulosin—Skin disorder—Epirubicin—bone cancer	0.000261	0.00255	CcSEcCtD
Tamsulosin—Hyperhidrosis—Epirubicin—bone cancer	0.00026	0.00254	CcSEcCtD
Tamsulosin—Insomnia—Methotrexate—bone cancer	0.00026	0.00254	CcSEcCtD
Tamsulosin—Myalgia—Doxorubicin—bone cancer	0.00026	0.00253	CcSEcCtD
Tamsulosin—Arthralgia—Doxorubicin—bone cancer	0.00026	0.00253	CcSEcCtD
Tamsulosin—Chest pain—Doxorubicin—bone cancer	0.00026	0.00253	CcSEcCtD
Tamsulosin—Paraesthesia—Methotrexate—bone cancer	0.000258	0.00252	CcSEcCtD
Tamsulosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000258	0.00252	CcSEcCtD
Tamsulosin—Discomfort—Doxorubicin—bone cancer	0.000257	0.0025	CcSEcCtD
Tamsulosin—Dyspnoea—Methotrexate—bone cancer	0.000256	0.0025	CcSEcCtD
Tamsulosin—Somnolence—Methotrexate—bone cancer	0.000256	0.00249	CcSEcCtD
Tamsulosin—Dyspepsia—Methotrexate—bone cancer	0.000253	0.00247	CcSEcCtD
Tamsulosin—Hypotension—Epirubicin—bone cancer	0.000251	0.00245	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Methotrexate—bone cancer	0.000248	0.00242	CcSEcCtD
Tamsulosin—Fatigue—Methotrexate—bone cancer	0.000248	0.00242	CcSEcCtD
Tamsulosin—Infection—Doxorubicin—bone cancer	0.000247	0.00241	CcSEcCtD
Tamsulosin—Pain—Methotrexate—bone cancer	0.000246	0.0024	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000245	0.00239	CcSEcCtD
Tamsulosin—Shock—Doxorubicin—bone cancer	0.000245	0.00239	CcSEcCtD
Tamsulosin—Nervous system disorder—Doxorubicin—bone cancer	0.000244	0.00238	CcSEcCtD
Tamsulosin—Insomnia—Epirubicin—bone cancer	0.000243	0.00238	CcSEcCtD
Tamsulosin—Tachycardia—Doxorubicin—bone cancer	0.000243	0.00237	CcSEcCtD
Tamsulosin—Skin disorder—Doxorubicin—bone cancer	0.000242	0.00236	CcSEcCtD
Tamsulosin—Paraesthesia—Epirubicin—bone cancer	0.000242	0.00236	CcSEcCtD
Tamsulosin—Hyperhidrosis—Doxorubicin—bone cancer	0.000241	0.00235	CcSEcCtD
Tamsulosin—Dyspnoea—Epirubicin—bone cancer	0.00024	0.00234	CcSEcCtD
Tamsulosin—Somnolence—Epirubicin—bone cancer	0.000239	0.00233	CcSEcCtD
Tamsulosin—Feeling abnormal—Methotrexate—bone cancer	0.000237	0.00231	CcSEcCtD
Tamsulosin—Dyspepsia—Epirubicin—bone cancer	0.000237	0.00231	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Methotrexate—bone cancer	0.000235	0.00229	CcSEcCtD
Tamsulosin—Hypotension—Doxorubicin—bone cancer	0.000233	0.00227	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Epirubicin—bone cancer	0.000232	0.00227	CcSEcCtD
Tamsulosin—Fatigue—Epirubicin—bone cancer	0.000232	0.00226	CcSEcCtD
Tamsulosin—Constipation—Epirubicin—bone cancer	0.00023	0.00225	CcSEcCtD
Tamsulosin—Pain—Epirubicin—bone cancer	0.00023	0.00225	CcSEcCtD
Tamsulosin—Urticaria—Methotrexate—bone cancer	0.000228	0.00223	CcSEcCtD
Tamsulosin—Body temperature increased—Methotrexate—bone cancer	0.000227	0.00222	CcSEcCtD
Tamsulosin—Abdominal pain—Methotrexate—bone cancer	0.000227	0.00222	CcSEcCtD
Tamsulosin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000227	0.00221	CcSEcCtD
Tamsulosin—Insomnia—Doxorubicin—bone cancer	0.000225	0.0022	CcSEcCtD
Tamsulosin—Paraesthesia—Doxorubicin—bone cancer	0.000223	0.00218	CcSEcCtD
Tamsulosin—Dyspnoea—Doxorubicin—bone cancer	0.000222	0.00217	CcSEcCtD
Tamsulosin—Feeling abnormal—Epirubicin—bone cancer	0.000222	0.00216	CcSEcCtD
Tamsulosin—Somnolence—Doxorubicin—bone cancer	0.000221	0.00216	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Epirubicin—bone cancer	0.00022	0.00215	CcSEcCtD
Tamsulosin—Dyspepsia—Doxorubicin—bone cancer	0.000219	0.00214	CcSEcCtD
Tamsulosin—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000215	0.0021	CcSEcCtD
Tamsulosin—Fatigue—Doxorubicin—bone cancer	0.000215	0.00209	CcSEcCtD
Tamsulosin—Urticaria—Epirubicin—bone cancer	0.000214	0.00209	CcSEcCtD
Tamsulosin—Pain—Doxorubicin—bone cancer	0.000213	0.00208	CcSEcCtD
Tamsulosin—Constipation—Doxorubicin—bone cancer	0.000213	0.00208	CcSEcCtD
Tamsulosin—Body temperature increased—Epirubicin—bone cancer	0.000213	0.00208	CcSEcCtD
Tamsulosin—Abdominal pain—Epirubicin—bone cancer	0.000213	0.00208	CcSEcCtD
Tamsulosin—Hypersensitivity—Methotrexate—bone cancer	0.000212	0.00207	CcSEcCtD
Tamsulosin—Asthenia—Methotrexate—bone cancer	0.000206	0.00201	CcSEcCtD
Tamsulosin—Feeling abnormal—Doxorubicin—bone cancer	0.000205	0.002	CcSEcCtD
Tamsulosin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000204	0.00199	CcSEcCtD
Tamsulosin—Pruritus—Methotrexate—bone cancer	0.000203	0.00199	CcSEcCtD
Tamsulosin—Hypersensitivity—Epirubicin—bone cancer	0.000198	0.00193	CcSEcCtD
Tamsulosin—Urticaria—Doxorubicin—bone cancer	0.000198	0.00193	CcSEcCtD
Tamsulosin—Abdominal pain—Doxorubicin—bone cancer	0.000197	0.00192	CcSEcCtD
Tamsulosin—Body temperature increased—Doxorubicin—bone cancer	0.000197	0.00192	CcSEcCtD
Tamsulosin—Diarrhoea—Methotrexate—bone cancer	0.000197	0.00192	CcSEcCtD
Tamsulosin—Asthenia—Epirubicin—bone cancer	0.000193	0.00188	CcSEcCtD
Tamsulosin—Pruritus—Epirubicin—bone cancer	0.00019	0.00186	CcSEcCtD
Tamsulosin—Dizziness—Methotrexate—bone cancer	0.00019	0.00186	CcSEcCtD
Tamsulosin—Diarrhoea—Epirubicin—bone cancer	0.000184	0.0018	CcSEcCtD
Tamsulosin—Hypersensitivity—Doxorubicin—bone cancer	0.000183	0.00179	CcSEcCtD
Tamsulosin—Vomiting—Methotrexate—bone cancer	0.000183	0.00178	CcSEcCtD
Tamsulosin—Rash—Methotrexate—bone cancer	0.000181	0.00177	CcSEcCtD
Tamsulosin—Dermatitis—Methotrexate—bone cancer	0.000181	0.00177	CcSEcCtD
Tamsulosin—Headache—Methotrexate—bone cancer	0.00018	0.00176	CcSEcCtD
Tamsulosin—Asthenia—Doxorubicin—bone cancer	0.000179	0.00174	CcSEcCtD
Tamsulosin—Dizziness—Epirubicin—bone cancer	0.000178	0.00174	CcSEcCtD
Tamsulosin—Pruritus—Doxorubicin—bone cancer	0.000176	0.00172	CcSEcCtD
Tamsulosin—Vomiting—Epirubicin—bone cancer	0.000171	0.00167	CcSEcCtD
Tamsulosin—Nausea—Methotrexate—bone cancer	0.000171	0.00167	CcSEcCtD
Tamsulosin—Diarrhoea—Doxorubicin—bone cancer	0.00017	0.00166	CcSEcCtD
Tamsulosin—Rash—Epirubicin—bone cancer	0.00017	0.00166	CcSEcCtD
Tamsulosin—Dermatitis—Epirubicin—bone cancer	0.000169	0.00165	CcSEcCtD
Tamsulosin—Headache—Epirubicin—bone cancer	0.000169	0.00165	CcSEcCtD
Tamsulosin—Dizziness—Doxorubicin—bone cancer	0.000165	0.00161	CcSEcCtD
Tamsulosin—Nausea—Epirubicin—bone cancer	0.00016	0.00156	CcSEcCtD
Tamsulosin—Vomiting—Doxorubicin—bone cancer	0.000158	0.00154	CcSEcCtD
Tamsulosin—Rash—Doxorubicin—bone cancer	0.000157	0.00153	CcSEcCtD
Tamsulosin—Dermatitis—Doxorubicin—bone cancer	0.000157	0.00153	CcSEcCtD
Tamsulosin—Headache—Doxorubicin—bone cancer	0.000156	0.00152	CcSEcCtD
Tamsulosin—Nausea—Doxorubicin—bone cancer	0.000148	0.00144	CcSEcCtD
Tamsulosin—DRD2—Circadian rythm related genes—CDK4—bone cancer	4.44e-05	0.00211	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—GRM4—bone cancer	4.41e-05	0.0021	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—RGS1—bone cancer	4.41e-05	0.0021	CbGpPWpGaD
Tamsulosin—HTR7—Circadian rythm related genes—JUN—bone cancer	4.4e-05	0.00209	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—GRM1—bone cancer	4.39e-05	0.00209	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—GRM1—bone cancer	4.39e-05	0.00209	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—NDUFA12—bone cancer	4.35e-05	0.00207	CbGpPWpGaD
Tamsulosin—ADRA1A—AMPK Signaling—TP53—bone cancer	4.28e-05	0.00204	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—RGS1—bone cancer	4.27e-05	0.00203	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—GRM4—bone cancer	4.27e-05	0.00203	CbGpPWpGaD
Tamsulosin—HTR1A—GPCR downstream signaling—GRM1—bone cancer	4.21e-05	0.00201	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—RGS1—bone cancer	4.2e-05	0.002	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—GRM4—bone cancer	4.2e-05	0.002	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR ligand binding—SMO—bone cancer	4.13e-05	0.00197	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	4.11e-05	0.00196	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	4.11e-05	0.00196	CbGpPWpGaD
Tamsulosin—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.08e-05	0.00194	CbGpPWpGaD
Tamsulosin—CYP2D6—Biological oxidations—GSTP1—bone cancer	4.05e-05	0.00193	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—GRM1—bone cancer	4.01e-05	0.00191	CbGpPWpGaD
Tamsulosin—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	3.99e-05	0.0019	CbGpPWpGaD
Tamsulosin—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	3.99e-05	0.0019	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—RGS1—bone cancer	3.88e-05	0.00185	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—GRM4—bone cancer	3.88e-05	0.00185	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—GRM1—bone cancer	3.83e-05	0.00182	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	3.82e-05	0.00182	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	3.82e-05	0.00182	CbGpPWpGaD
Tamsulosin—DRD3—Circadian rythm related genes—JUN—bone cancer	3.74e-05	0.00178	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—GRM4—bone cancer	3.73e-05	0.00178	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—RGS1—bone cancer	3.73e-05	0.00178	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—GRM1—bone cancer	3.7e-05	0.00176	CbGpPWpGaD
Tamsulosin—ADRA2A—Hemostasis—SPARC—bone cancer	3.69e-05	0.00176	CbGpPWpGaD
Tamsulosin—HTR7—GPCR downstream signaling—GNA11—bone cancer	3.67e-05	0.00174	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—GRM1—bone cancer	3.65e-05	0.00174	CbGpPWpGaD
Tamsulosin—HTR7—Signaling by GPCR—SMO—bone cancer	3.64e-05	0.00173	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—NT5C3A—bone cancer	3.61e-05	0.00172	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	3.57e-05	0.0017	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—RGS1—bone cancer	3.52e-05	0.00168	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—GRM4—bone cancer	3.52e-05	0.00168	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—GRM4—bone cancer	3.47e-05	0.00165	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—RGS1—bone cancer	3.47e-05	0.00165	CbGpPWpGaD
Tamsulosin—ADRA2A—Hemostasis—GNA11—bone cancer	3.38e-05	0.00161	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—GRM1—bone cancer	3.36e-05	0.0016	CbGpPWpGaD
Tamsulosin—HTR7—Signaling by GPCR—GNA11—bone cancer	3.33e-05	0.00158	CbGpPWpGaD
Tamsulosin—HTR7—GPCR downstream signaling—IL3—bone cancer	3.32e-05	0.00158	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	3.31e-05	0.00158	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—GRM1—bone cancer	3.24e-05	0.00154	CbGpPWpGaD
Tamsulosin—DRD3—GPCR downstream signaling—GNA11—bone cancer	3.12e-05	0.00148	CbGpPWpGaD
Tamsulosin—ADRA1D—GPCR downstream signaling—GNA11—bone cancer	3.12e-05	0.00148	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—SMO—bone cancer	3.09e-05	0.00147	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—SMO—bone cancer	3.09e-05	0.00147	CbGpPWpGaD
Tamsulosin—ADRA2A—Hemostasis—IL3—bone cancer	3.06e-05	0.00146	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—GRM1—bone cancer	3.05e-05	0.00145	CbGpPWpGaD
Tamsulosin—HTR7—Signaling by GPCR—IL3—bone cancer	3.02e-05	0.00144	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—GRM1—bone cancer	3.01e-05	0.00143	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—RGS1—bone cancer	2.99e-05	0.00142	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—GRM4—bone cancer	2.99e-05	0.00142	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—RGS1—bone cancer	2.99e-05	0.00142	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—GRM4—bone cancer	2.99e-05	0.00142	CbGpPWpGaD
Tamsulosin—HTR7—Circadian rythm related genes—TP53—bone cancer	2.9e-05	0.00138	CbGpPWpGaD
Tamsulosin—DRD2—Circadian rythm related genes—JUN—bone cancer	2.86e-05	0.00136	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—NDUFA12—bone cancer	2.84e-05	0.00135	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—GNA11—bone cancer	2.83e-05	0.00135	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—GNA11—bone cancer	2.83e-05	0.00135	CbGpPWpGaD
Tamsulosin—ADRA1D—GPCR downstream signaling—IL3—bone cancer	2.83e-05	0.00135	CbGpPWpGaD
Tamsulosin—DRD3—GPCR downstream signaling—IL3—bone cancer	2.83e-05	0.00135	CbGpPWpGaD
Tamsulosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	2.78e-05	0.00133	CbGpPWpGaD
Tamsulosin—HTR1A—GPCR downstream signaling—GNA11—bone cancer	2.72e-05	0.00129	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—SMO—bone cancer	2.7e-05	0.00128	CbGpPWpGaD
Tamsulosin—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.65e-05	0.00126	CbGpPWpGaD
Tamsulosin—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.61e-05	0.00124	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—GRM4—bone cancer	2.61e-05	0.00124	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—RGS1—bone cancer	2.61e-05	0.00124	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—GRM1—bone cancer	2.59e-05	0.00124	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—GRM1—bone cancer	2.59e-05	0.00124	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—GNA11—bone cancer	2.59e-05	0.00123	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—SMO—bone cancer	2.57e-05	0.00122	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—IL3—bone cancer	2.57e-05	0.00122	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—IL3—bone cancer	2.57e-05	0.00122	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—GRM4—bone cancer	2.48e-05	0.00118	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—RGS1—bone cancer	2.48e-05	0.00118	CbGpPWpGaD
Tamsulosin—DRD3—Circadian rythm related genes—TP53—bone cancer	2.47e-05	0.00117	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—GNA11—bone cancer	2.47e-05	0.00117	CbGpPWpGaD
Tamsulosin—HTR1A—GPCR downstream signaling—IL3—bone cancer	2.46e-05	0.00117	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—GNA11—bone cancer	2.38e-05	0.00114	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—SMO—bone cancer	2.37e-05	0.00113	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—NT5C3A—bone cancer	2.35e-05	0.00112	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—GNA11—bone cancer	2.35e-05	0.00112	CbGpPWpGaD
Tamsulosin—ADRA1B—GPCR downstream signaling—IL3—bone cancer	2.35e-05	0.00112	CbGpPWpGaD
Tamsulosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	2.31e-05	0.0011	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	2.3e-05	0.00109	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—GRM4—bone cancer	2.29e-05	0.00109	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—RGS1—bone cancer	2.29e-05	0.00109	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—SMO—bone cancer	2.28e-05	0.00109	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—GRM1—bone cancer	2.26e-05	0.00108	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—IL3—bone cancer	2.24e-05	0.00106	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—GRM4—bone cancer	2.21e-05	0.00105	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—RGS1—bone cancer	2.21e-05	0.00105	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—GNA11—bone cancer	2.17e-05	0.00103	CbGpPWpGaD
Tamsulosin—DRD2—GPCR downstream signaling—IL3—bone cancer	2.16e-05	0.00103	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—GRM1—bone cancer	2.15e-05	0.00103	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—SMO—bone cancer	2.15e-05	0.00102	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	2.13e-05	0.00102	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—IL3—bone cancer	2.13e-05	0.00101	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—SMO—bone cancer	2.12e-05	0.00101	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—GNA11—bone cancer	2.09e-05	0.000993	CbGpPWpGaD
Tamsulosin—ADRA1A—GPCR downstream signaling—IL3—bone cancer	2.08e-05	0.000992	CbGpPWpGaD
Tamsulosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	2.05e-05	0.000977	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—GRM4—bone cancer	2.05e-05	0.000976	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—RGS1—bone cancer	2.05e-05	0.000976	CbGpPWpGaD
Tamsulosin—ADRA2A—Hemostasis—PLAU—bone cancer	2.01e-05	0.000956	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—GRM1—bone cancer	1.99e-05	0.000945	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—GNA11—bone cancer	1.97e-05	0.000936	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—IL3—bone cancer	1.96e-05	0.000935	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—GNA11—bone cancer	1.94e-05	0.000923	CbGpPWpGaD
Tamsulosin—ADRA2A—GPCR downstream signaling—IL3—bone cancer	1.94e-05	0.000921	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—GRM1—bone cancer	1.91e-05	0.000911	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—IL3—bone cancer	1.89e-05	0.000901	CbGpPWpGaD
Tamsulosin—DRD2—Circadian rythm related genes—TP53—bone cancer	1.89e-05	0.000899	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NDUFA12—bone cancer	1.85e-05	0.000883	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—SMO—bone cancer	1.83e-05	0.00087	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—SMO—bone cancer	1.83e-05	0.00087	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—ATF1—bone cancer	1.83e-05	0.00087	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—IL3—bone cancer	1.78e-05	0.000849	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—GRM1—bone cancer	1.78e-05	0.000846	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—IL3—bone cancer	1.76e-05	0.000837	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—GNA11—bone cancer	1.67e-05	0.000796	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—GNA11—bone cancer	1.67e-05	0.000796	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—SMO—bone cancer	1.59e-05	0.000758	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—ENO2—bone cancer	1.58e-05	0.000752	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—ATF1—bone cancer	1.55e-05	0.00074	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—ATF1—bone cancer	1.55e-05	0.00074	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—NT5C3A—bone cancer	1.54e-05	0.000731	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TGFBR2—bone cancer	1.52e-05	0.000726	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—SMO—bone cancer	1.52e-05	0.000722	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—IL3—bone cancer	1.52e-05	0.000722	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—IL3—bone cancer	1.52e-05	0.000722	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—DHFR—bone cancer	1.47e-05	0.000698	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—GNA11—bone cancer	1.46e-05	0.000694	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—IGF1R—bone cancer	1.43e-05	0.000683	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—SMO—bone cancer	1.4e-05	0.000666	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—GNA11—bone cancer	1.39e-05	0.000661	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—GNA11—bone cancer	1.37e-05	0.000652	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—ATF1—bone cancer	1.35e-05	0.000645	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—SMO—bone cancer	1.35e-05	0.000642	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IL3—bone cancer	1.32e-05	0.000629	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	1.3e-05	0.000617	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TGFBR2—bone cancer	1.3e-05	0.000617	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—ATF1—bone cancer	1.29e-05	0.000614	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—GNA11—bone cancer	1.28e-05	0.000609	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IL3—bone cancer	1.26e-05	0.000599	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—SMO—bone cancer	1.25e-05	0.000596	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—CYP3A4—bone cancer	1.24e-05	0.000591	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—GNA11—bone cancer	1.23e-05	0.000587	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—IGF1R—bone cancer	1.22e-05	0.000581	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—IGF1R—bone cancer	1.22e-05	0.000581	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—ATF1—bone cancer	1.19e-05	0.000566	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IL3—bone cancer	1.16e-05	0.000552	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—ATF1—bone cancer	1.15e-05	0.000546	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—GNA11—bone cancer	1.15e-05	0.000545	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TGFBR2—bone cancer	1.13e-05	0.000538	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IL3—bone cancer	1.12e-05	0.000532	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	1.08e-05	0.000512	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—ATF1—bone cancer	1.06e-05	0.000507	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—IGF1R—bone cancer	1.06e-05	0.000506	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—GSTP1—bone cancer	1.06e-05	0.000506	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—KIT—bone cancer	1.04e-05	0.000495	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IL3—bone cancer	1.04e-05	0.000494	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—ENO2—bone cancer	1.03e-05	0.00049	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—IGF1R—bone cancer	1.01e-05	0.000482	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TGFBR2—bone cancer	9.92e-06	0.000472	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—BRAF—bone cancer	9.78e-06	0.000466	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	9.56e-06	0.000455	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—DHFR—bone cancer	9.55e-06	0.000455	CbGpPWpGaD
Tamsulosin—HTR7—Signaling by GPCR—EGFR—bone cancer	9.48e-06	0.000451	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—IGF1R—bone cancer	9.33e-06	0.000444	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—IGF1R—bone cancer	8.99e-06	0.000428	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—GNA11—bone cancer	8.92e-06	0.000425	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	8.88e-06	0.000423	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—KIT—bone cancer	8.85e-06	0.000421	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—KIT—bone cancer	8.85e-06	0.000421	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—IGF1R—bone cancer	8.35e-06	0.000398	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—BRAF—bone cancer	8.31e-06	0.000396	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—BRAF—bone cancer	8.31e-06	0.000396	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—MDM2—bone cancer	8.19e-06	0.00039	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—CYP3A4—bone cancer	8.09e-06	0.000385	CbGpPWpGaD
Tamsulosin—ADRA2A—Hemostasis—TP53—bone cancer	8.08e-06	0.000384	CbGpPWpGaD
Tamsulosin—DRD3—Signaling by GPCR—EGFR—bone cancer	8.06e-06	0.000384	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling by GPCR—EGFR—bone cancer	8.06e-06	0.000384	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—KIT—bone cancer	7.71e-06	0.000367	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—KIT—bone cancer	7.34e-06	0.00035	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—BRAF—bone cancer	7.25e-06	0.000345	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—JUN—bone cancer	7.12e-06	0.000339	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling by GPCR—EGFR—bone cancer	7.02e-06	0.000334	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MDM2—bone cancer	6.97e-06	0.000332	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MDM2—bone cancer	6.97e-06	0.000332	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—MMP9—bone cancer	6.93e-06	0.00033	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—GSTP1—bone cancer	6.92e-06	0.000329	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—BRAF—bone cancer	6.9e-06	0.000329	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—KIT—bone cancer	6.77e-06	0.000322	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—ENO2—bone cancer	6.73e-06	0.00032	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling by GPCR—EGFR—bone cancer	6.69e-06	0.000318	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—KIT—bone cancer	6.52e-06	0.00031	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—BRAF—bone cancer	6.36e-06	0.000303	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—DHFR—bone cancer	6.24e-06	0.000297	CbGpPWpGaD
Tamsulosin—DRD2—Signaling by GPCR—EGFR—bone cancer	6.17e-06	0.000294	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—BRAF—bone cancer	6.13e-06	0.000292	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MDM2—bone cancer	6.07e-06	0.000289	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—KIT—bone cancer	6.06e-06	0.000288	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—JUN—bone cancer	6.06e-06	0.000288	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—JUN—bone cancer	6.06e-06	0.000288	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling by GPCR—EGFR—bone cancer	5.94e-06	0.000283	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—MMP9—bone cancer	5.89e-06	0.00028	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—MMP9—bone cancer	5.89e-06	0.00028	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GNA11—bone cancer	5.83e-06	0.000278	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MDM2—bone cancer	5.78e-06	0.000275	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—BRAF—bone cancer	5.7e-06	0.000271	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—EGFR—bone cancer	5.6e-06	0.000267	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling by GPCR—EGFR—bone cancer	5.52e-06	0.000263	CbGpPWpGaD
Tamsulosin—ADRA2A—Metabolism—PTGS2—bone cancer	5.5e-06	0.000262	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MDM2—bone cancer	5.33e-06	0.000254	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—JUN—bone cancer	5.28e-06	0.000251	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MDM2—bone cancer	5.14e-06	0.000245	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—MMP9—bone cancer	5.13e-06	0.000244	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—JUN—bone cancer	5.03e-06	0.000239	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—MMP9—bone cancer	4.89e-06	0.000233	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MDM2—bone cancer	4.77e-06	0.000227	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—EGFR—bone cancer	4.76e-06	0.000227	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—EGFR—bone cancer	4.76e-06	0.000227	CbGpPWpGaD
Tamsulosin—HTR7—Signaling Pathways—TP53—bone cancer	4.7e-06	0.000224	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—JUN—bone cancer	4.63e-06	0.000221	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—GSTP1—bone cancer	4.52e-06	0.000215	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—MMP9—bone cancer	4.51e-06	0.000215	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—JUN—bone cancer	4.46e-06	0.000213	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—MMP9—bone cancer	4.34e-06	0.000207	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—EGFR—bone cancer	4.15e-06	0.000198	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—JUN—bone cancer	4.15e-06	0.000197	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—MMP9—bone cancer	4.04e-06	0.000192	CbGpPWpGaD
Tamsulosin—DRD3—Signaling Pathways—TP53—bone cancer	4e-06	0.00019	CbGpPWpGaD
Tamsulosin—ADRA1D—Signaling Pathways—TP53—bone cancer	4e-06	0.00019	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—EGFR—bone cancer	3.95e-06	0.000188	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—EGFR—bone cancer	3.64e-06	0.000173	CbGpPWpGaD
Tamsulosin—CYP2D6—Metabolism—PTGS2—bone cancer	3.58e-06	0.000171	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—EGFR—bone cancer	3.51e-06	0.000167	CbGpPWpGaD
Tamsulosin—HTR1A—Signaling Pathways—TP53—bone cancer	3.48e-06	0.000166	CbGpPWpGaD
Tamsulosin—ADRA1B—Signaling Pathways—TP53—bone cancer	3.32e-06	0.000158	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—EGFR—bone cancer	3.26e-06	0.000155	CbGpPWpGaD
Tamsulosin—DRD2—Signaling Pathways—TP53—bone cancer	3.06e-06	0.000146	CbGpPWpGaD
Tamsulosin—ADRA1A—Signaling Pathways—TP53—bone cancer	2.95e-06	0.00014	CbGpPWpGaD
Tamsulosin—ADRA2A—Signaling Pathways—TP53—bone cancer	2.74e-06	0.00013	CbGpPWpGaD
Tamsulosin—CYP3A4—Metabolism—PTGS2—bone cancer	2.34e-06	0.000112	CbGpPWpGaD
